Stock 605077 ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Zhejiang Huakang Pharmaceutical Co., Ltd.

Equities

605077

CNE100005477

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-28 EDT 		5-day change 1st Jan Change
16.7 CNY +1.15% Intraday chart for Zhejiang Huakang Pharmaceutical Co., Ltd. -7.42% +0.32%
04-25 Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-18 Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants
MT
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory
MT
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd.
CI
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan
MT
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million.
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. signed an agreement to acquire Gaomi Tongli Sugar Co., Ltd. from Qiu Fazhong, Ma Yongan, Zhang Xiulan, Peng Jie, Zhang Jie, Sun Yanfa, Shan Yitao, Xue Youhe, Wang Xia, Wang Xia, Sun Tao, Li Yanxi, Song Xiufang, Jiang Faqi, Ren Pingxu, Xue Jikui, Lu Guangzhao, Pang Jiyi, Zhang Zuojiang, Ge Lianzhen, Jiao Yuxia, Du Xiujun, Wang Chuanxiang, Yang Fuhong for approximately CNY 100 million.
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 605077 Stock
  4. News Zhejiang Huakang Pharmaceutical Co., Ltd.
  5. Highlights